Category: <span>extending mesothelioma survival</span>

Category: extending mesothelioma survival

chemotherapy clinical trial, chemotherapy for mesothelioma, extending mesothelioma survival, Mesothelioma News, Mesothelioma treatment, nintedanib

Mesothelioma Trial for Nintedanib Shows Positive Results

 

Researchers have reported more promising results from an international, multicenter phase II clinical trial of the drug nintedanib, moving it another step closer to standard-of-care treatment for pleural mesothelioma. Nintedanib is a small-molecule enzyme inhibitor being studied as a way to increase the effectiveness of chemotherapy on mesothelioma and certain types of lung cancer. Researchers…

The post Mesothelioma Trial for Nintedanib Shows Positive Results appeared first on Mesothelioma Center – Vital Services for Cancer Patients & Families.

antitumor, extending mesothelioma survival, malaria drug, malignant pleural mesothelioma, mesothelioma clinical trial, Mesothelioma News, Mesothelioma treatment, onconase, onconase clinical trial, tongji university

Study: Onconase, Malaria Drug Extends Mesothelioma Survival

 

A new treatment combining two existing drugs — one derived from frog eggs and another given to combat malaria — may be the key to extending mesothelioma survival. Scientists at Tongji University in Shanghai, China, discovered that mixing Onconase, an enzyme present in early-stage leopard frog embryos, with antimalarial drug dihydroartemisinin (DHA) synergistically suppressed growth…

The post Study: Onconase, Malaria Drug Extends Mesothelioma Survival appeared first on Mesothelioma Center – Vital Services for Cancer Patients & Families.